Skip to main content
Cuorips Inc. logo

Cuorips Inc. — Investor Relations & Filings

Ticker · 4894 ISIN · JP3266030000 T Manufacturing
Open in API
Filings indexed 23 across all filing types
Latest filing 2025-11-13 Regulatory Filings
Country JP Japan
Listing T 4894

About Cuorips Inc.

https://cuorips.co.jp/en/

Cuorips Inc. is a regenerative medicine company that originated as a spin-off from Osaka University. The company specializes in the research, development, and commercialization of cellular and tissue-based products derived from induced pluripotent stem (iPS) cells. Its primary product is a cardiac myocyte sheet, a novel therapy developed for treating severe heart failure. This cardiac tissue sheet, created from iPS cells, is designed to be grafted onto a patient's heart to restore function. In addition to its proprietary product pipeline, Cuorips provides contract services for the development and manufacturing of cell processing products, contributing to the advancement of medical care through cutting-edge technology.

Recent filings

Filing Released Lang Actions
確認書
Regulatory Filings Classification · 1% confidence The document is titled '確認書' (Confirmation Letter) and explicitly references '金融商品取引法第24条の５の２第１項' (Article 24-5-2, Paragraph 1 of the Financial Instruments and Exchange Act). It serves as an officer certification confirming the accuracy of a semi-annual report. According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations should be classified as Regulatory Filings (RNS), even if they reference a specific report type. H1 2025
2025-11-13 Japanese
半期報告書－第10期(2025/04/01－2026/03/31)
Interim / Quarterly Report Classification · 1% confidence The document is a '半期報告書' (Semi-Annual Report) filed by Cuorips Inc. with the Kanto Local Finance Bureau under the Financial Instruments and Exchange Act. It contains comprehensive financial statements, management analysis (MD&A), and corporate information for the interim period (April 1, 2025, to September 30, 2025). This fits the definition of an Interim/Quarterly Report (IR). H1 2026
2025-11-13 Japanese
臨時報告書
AGM Information Classification · 1% confidence The document is titled "臨時報告書" (Extraordinary Report) and explicitly states in Section 1 that it is being filed pursuant to Article 24-5, Paragraph 4 of the Financial Instruments and Exchange Act and related Cabinet Office Ordinance because resolutions were passed at the company's 9th Annual General Meeting (AGM) held on June 19, 2025. Section 2 details the resolutions passed, including the election of directors and revisions to director/auditor compensation. This document reports the official results of shareholder votes from a general meeting. This aligns perfectly with the definition for 'Declaration of Voting Results & Voting Rights Announcements' (DVA), which covers official results from shareholder votes at any general meeting.
2025-06-25 Japanese
確認書
Regulatory Filings Classification · 1% confidence The document is titled '確認書' (Confirmation Letter) and explicitly references '金融商品取引法第24条の４の２第１項' (Article 24-4-2, Paragraph 1 of the Financial Instruments and Exchange Act). It serves as an officer certification confirming the accuracy of the Annual Securities Report (有価証券報告書). According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations, even if they reference a report, should be classified as Regulatory Filings (RNS) rather than the report itself. FY 2025
2025-06-20 Japanese
内部統制報告書－第9期(2024/04/01－2025/03/31)
Governance Information Classification · 1% confidence The document is explicitly titled "内部統制報告書" (Internal Control Report) in the header and within the filing details table. It references the legal basis as Article 24-4-4, Paragraph 1 of the Financial Instruments and Exchange Act (金融商品取引法第24条の４の４第１項), which mandates the filing of an Internal Control Report by listed companies in Japan. The content discusses the framework, scope, criteria, and conclusion regarding the effectiveness of internal controls over financial reporting as of the fiscal year-end (March 31, 2025). This directly corresponds to the requirements for an Internal Control Report, which is a specific type of annual disclosure in Japan, often filed alongside the 10-K equivalent (which is the 10-K itself, but this specific Japanese document type is best classified under a general Audit/Regulatory category if a specific 'Internal Control Report' code isn't available. Given the provided list, 'AR' (Audit Report / Information) is the closest fit as it deals with internal controls and assurance over financial reporting, although '10-K' is the comprehensive annual report. Since this is a specific control report, and not the full 10-K, 'AR' is a better fit than '10-K' based on the provided definitions, as AR covers 'applied accounting principles, and results of internal or regulatory stress tests (excluding full Annual Reports)'. However, in many contexts, the Japanese Internal Control Report is intrinsically linked to the annual filing process. Given the highly specific nature of the document (Internal Control Report), and the lack of a dedicated code, I will re-evaluate the options. 'AR' seems the most appropriate category for assurance-related reports that are not the full annual report. The document is substantial and contains detailed analysis, not just an announcement, so RPA/RNS is incorrect. I will select AR.
2025-06-20 Japanese
有価証券報告書－第9期(2024/04/01－2025/03/31)
Annual Report Classification · 1% confidence The document is a Japanese 'Yuka Shoken Hokokusho' (Securities Report), which is the standard annual financial filing required by the Financial Instruments and Exchange Act in Japan. It contains comprehensive financial statements, management discussion, and corporate information for the fiscal year ending March 31, 2025. This corresponds to the 10-K equivalent in the provided classification schema. FY 2025
2025-06-20 Japanese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.